SkinVive in Delhi
SkinVive in Delhi
SkinVive has been marketed, not unfairly, as an injectable moisturiser. The comparison is useful because it explains what the product is for — hydration and smoothness rather than volume or shape — and misleading because it makes the treatment sound like a facial. It is not a facial. It is a hyaluronic acid gel implant, stabilised with a chemical cross-linker, deposited into the dermis as dozens of tiny droplets through a needle. That is a rather different proposition from a serum, and it deserves to be described accurately.
It is also, and this is the part almost nobody in Delhi will tell you, the same product as Juvéderm Volite. Identical formulation, identical manufacturer, different brand name for different markets. If you have been quoted for one and offered the other, you have not been misled — but you should have been told.
At Sarayu Clinics in Greater Kailash, SkinVive is administered by facial plastic and maxillofacial surgeon Dr. Adarsh Tripathi. What follows is the version of this information we would want if we were the patient — including the approval boundaries, the actual trial numbers, and the small print about what this product contains.
The short answer : SkinVive by Juvéderm is a hyaluronic acid microdroplet injectable made by Allergan Aesthetics (AbbVie). It received US FDA approval in May 2023 for intradermal injection to improve the smoothness of the CHEEKS in adults aged 21 and over — the first and only injectable with that specific on-label indication. Internationally the identical product is sold as Juvéderm Volite (code VYC-12L). It is a VYCROSS gel, cross-linked with BDDE, and contains 0.3% lidocaine for comfort. It is injected as many tiny droplets across the cheek with an ultrafine 32-gauge needle, and it adds no volume and does not change facial shape. One session, with an optional touch-up at one month. Smoothness improves for up to six months; hydration for up to nine. In the pivotal trial of 209 people, 57.9% achieved at least a one-point improvement in cheek smoothness at one month. Approved for all skin types, Fitzpatrick I to VI. Delhi cost is roughly Rs 25,000–45,000 per syringe. It is bacterially fermented and contains no animal-derived material.
SkinVive and Juvéderm Volite Are the Same Product
This is the first thing you should know, and it appears on no Delhi clinic website we could find.
SkinVive is the brand name Allergan uses in the United States. Everywhere else — Europe, the UK, most of Asia, India — the identical product is sold as Juvéderm Volite. Its internal product code is VYC-12L. Same manufacturer, same VYCROSS formulation, same indication, same syringe. Only the label on the box differs.
Two practical consequences follow. First, if you are searching for SkinVive in Delhi, what you are most likely to be offered — and what may already be sitting in the clinic’s fridge — is Volite. That is not a substitution or a downgrade. It is the same thing. Second, price comparisons that treat them as separate products are meaningless. Ask the clinic which SKU they hold, and satisfy yourself that it is genuine Allergan product with intact packaging and a batch number, whichever name is printed on it.
Why does the name change?
Regulatory approval is granted market by market, and Allergan chose to launch the product in the United States under a new consumer-facing name after its FDA approval in May 2023, distinct from the Juvéderm filler line already established there. Elsewhere it retained the Volite name it had carried since its European launch. This is ordinary pharmaceutical brand practice — the same reason a familiar painkiller carries different names in different countries. It is not ordinary for clinics to leave patients unaware of it.
What SkinVive Actually Is ?
SkinVive is a smooth, clear, colourless gel implant. Three components define it, and each has a consequence patients ought to understand:
- Cross-linked hyaluronic acid, made with VYCROSS technology. The HA is stabilised using a chemical cross-linker called BDDE — 1,4-butanediol diglycidyl ether — which is what allows the gel to persist in the skin for months rather than dissolving in days. Cross-linking is why SkinVive lasts, and it is also why the FDA classifies it as a gel implant, in the same regulatory category as dermal fillers.
- 3% lidocaine. A local anaesthetic is built into the syringe. This is a real and underappreciated advantage: it makes SkinVive considerably more comfortable to receive than Profhilo or Rejuran, neither of which contains lidocaine.
- Trace Gram-positive bacterial proteins. The hyaluronic acid is produced by bacterial fermentation, which means the product contains no animal-derived material — it is suitable for vegetarian and Jain patients. It also means trace bacterial proteins remain from the manufacturing process, and these constitute a genuine allergy contraindication that must be screened for.
Once deposited as microdroplets in the dermis, the gel does not stay as discrete beads. It disperses into an even layer beneath the surface, drawing and holding water. The skin becomes better hydrated from within — which is what produces the smoothness, the improved texture, and the quality patients describe as glow.
An honest correction: this is a filler, technically
Delhi pages describe SkinVive as an injectable moisturiser or a skin booster, and functionally that is what it does. But it is BDDE-crosslinked and the FDA classifies it as a gel implant — the same device category as a dermal filler. This matters for one reason. Any hyaluronic acid injectable carries a small risk of unintentional injection into a blood vessel, and the consequences of that, while rare, can be serious and occasionally permanent. Profhilo, by contrast, contains no cross-linker at all. We are not telling you this to frighten you — the risk with superficial microdroplet placement is very low. We are telling you because a clinic describing it as ‘just hydration’ is describing the effect, not the product, and you are entitled to know which one you are being injected with and by whom.
What SkinVive Is Approved For — And What It Is Not ?
This section exists on no competitor page in Delhi, and it is the most clinically important thing here.
SkinVive’s FDA approval is narrow and specific: intradermal injection to improve facial skin smoothness of the cheeks, in adults aged 21 and over. That is the whole of the on-label indication. The manufacturer’s own safety information states plainly that safety and effectiveness for treatment in other areas of the body have not been established.
Area | Status | What that means for you |
Cheeks | ON-LABEL — FDA approved | Studied, approved, supported by trial data |
Under-eyes / periorbital | Off-label | Commonly offered. Not studied for this use. Thin skin; different risk profile |
Neck and décolletage | Off-label | Commonly offered. Safety and effectiveness not established |
Around the mouth / perioral | Off-label | Commonly offered. Not studied |
Backs of hands | Off-label | Commonly offered. Not studied |
Forehead, temples | Off-label | Not studied |
Off-label use is legal, common, and often perfectly reasonable — physicians exercise clinical judgement in every field of medicine, and a great deal of good practice begins off-label. It is not a scandal. But you should be told when it is happening, and told why, and given the option to choose a product that has been studied for the area in question. Being quietly treated off-label without that conversation is the part that is not acceptable.
At Sarayu, if we recommend SkinVive outside the cheeks we will say so explicitly, explain the reasoning, and set out the alternatives — for the under-eye area, for example, Rejuran I is purpose-formulated for periorbital skin, and our under-eye treatment page sets out the full diagnostic question of hollow versus shadow versus pigment versus texture.
What the Clinical Trial Actually Showed ?
Delhi pages promise glow. Here is the number behind it.
The pivotal US trial was a randomised, evaluator-blinded study of 209 participants. At one month, 57.9% of treated participants achieved at least a one-point improvement on a validated cheek smoothness scale. Patients also reported high satisfaction with how glowing, hydrated, refreshed and healthy their skin looked, sustained through six months, measured using a validated questionnaire.
Read that honestly. Roughly six in ten people saw a measurable improvement in smoothness at one month. That is a real, respectable result for a single-session treatment with essentially no downtime — and it is not everybody. It is also not a transformation. SkinVive improves the quality of skin that is already reasonably good. If your cheeks are deeply lined, significantly lax, or heavily scarred, this is not the product that will fix that, and a clinic promising otherwise is selling you the adjectives rather than the evidence.
Benefits of SkinVive
- Genuine, lasting hydration from within — cross-linked HA holds water in the dermis for months, at a depth no topical product reaches. Hydration benefits are reported for up to nine months.
- Improved cheek smoothness, with regulatory approval behind it — the only injectable with a specific FDA indication for this. That is a meaningful distinction from products used off-label for skin quality.
- No volume, no change to facial shape — microdroplets sit in the dermis and disperse. Your proportions, expression and structure are untouched.
- A single session — unlike Profhilo (two sessions) or Rejuran (three to four). One appointment, with an optional touch-up at one month.
- Built-in lidocaine — noticeably more comfortable than Profhilo and Rejuran, both of which are lidocaine-free. A small thing that matters a great deal in practice.
- Approved for all skin types, Fitzpatrick I to VI — the clinical trials included diverse populations. There is no pigmentation risk, because nothing here targets melanin or generates heat.
- Refined pore appearance and texture — as the dermis hydrates and plumps, the skin surface smooths and pore openings appear tighter.
- Animal-free — bacterially fermented HA, suitable for vegetarian and Jain patients. Unlike the salmon-derived polynucleotide boosters.
- Effectively no downtime — small bumps and mild redness settle within hours. Most patients return to their day immediately.
Areas We Treat
Listed honestly, with approval status shown, because you should know which is which:
- Cheeks — the on-label, FDA-approved indication, from the zygomatic arch down toward the jawline. This is where SkinVive belongs and where the evidence sits.
- Perioral area, neck, décolletage, hands, under-eyes — treated off-label at many clinics. We will discuss whether SkinVive is genuinely the best tool for these areas, or whether a product studied for them serves you better. Often it does.
Conditions & Concerns SkinVive Treats
- Dehydrated, dull, rough-textured cheek skin — the core indication.
- Fine lines and crepiness caused by dryness — not expression lines, which need Botox.
- Loss of radiance and ‘flat’-looking skin — the quality patients describe as skin that no longer catches light.
- Enlarged-looking pores — secondary to dermal hydration. See also open pores treatment.
- Skin dryness from pollution and urban exposure — a real dermatological factor in Delhi.
- A first injectable, for the cautious — nothing about your face changes. For patients nervous about injectables, this is often the gentlest possible introduction.
- Skin preparation before an event — with correct timing. Results appear at around one month, not one week.
The Procedure: Step by Step
- Skin assessment and honest suitability check. Tripathi assesses hydration, texture, skin quality and the specific area of concern. If your dominant problem is volume, sagging, pigment or scarring, SkinVive is the wrong treatment and you will hear that before you book it.
- Allergy screening. Specifically for lidocaine allergy, previous allergic reaction to hyaluronic acid fillers, a history of anaphylaxis or multiple severe allergies, and allergy to Gram-positive bacterial proteins. All four are contraindications.
- Product verification. Ask to see the sealed Allergan syringe, its batch number and packaging — whether it is labelled SkinVive or Juvéderm Volite. We will show you before it is opened.
- Topical anaesthetic is applied, though SkinVive contains 0.3% lidocaine itself, which does much of the work. This is the most comfortable of the skin-quality injectables.
- Microdroplet injection. An ultrafine 32-gauge needle deposits many small droplets across the cheek, spaced roughly five millimetres to a centimetre apart, so the gel distributes evenly. A typical session uses two to three millilitres and takes well under an hour.
- Immediate aftercare. Small bumps and mild redness are expected and settle within hours. A cool compress, and written instructions before you leave.
- Optional touch-up at one month. Assessed at review rather than assumed. Some patients need it; many do not.
- Every six to nine months to sustain the result.
Downtime & Aftercare
- First few hours: small bumps at the injection points and mild redness. These are the most common effects and they settle quickly — this is the lowest-downtime injectable in the skin-quality category.
- Possible for 1–4 weeks: mild swelling, small lumps, bruising, tenderness. Uncommon, usually minor, and self-resolving. Reported in the clinical data and worth knowing about.
- First 24 hours: avoid strenuous exercise, extensive sun or heat exposure, saunas, steam and alcohol.
- Do not book laser, chemical peel or other procedures immediately afterwards without telling your doctor. There is a possible risk of an inflammatory reaction at the treatment site. This is in the manufacturer’s own safety information and it is routinely ignored.
- Delay treatment if you have skin sores, pimples, rashes, hives, cysts or infection in the area.
- SPF 50+ daily. Standard, and non-negotiable.
- Return to work: the same day, in almost every case.
SkinVive Cost in Delhi
SkinVive, or Juvéderm Volite under its other name, is a premium imported Allergan product. Verified Delhi ranges:
Treatment | Typical cost (INR)* |
Consultation & skin quality assessment | Often nominal — confirmed when you book |
SkinVive / Juvéderm Volite — cheeks, single syringe | Rs 25,000 – Rs 45,000 |
Two syringes (fuller face coverage) | Rs 45,000 – Rs 80,000 |
Optional touch-up at one month | Quoted at review; often not required |
Off-label areas (neck, hands, perioral) — per syringe | Rs 25,000 – Rs 45,000 |
Maintenance session (every 6–9 months) | Rs 25,000 – Rs 45,000 |
Combination plan (with Botox or filler) | Package pricing after assessment |
*Indicative ranges only. SkinVive is genuinely cheaper per course than Profhilo or Rejuran, because it needs one session rather than two to four. When comparing the three, compare total course cost — that is where SkinVive looks most attractive, and it is a fair comparison to make.
Counterfeits and the two-name problem
Allergan products are heavily counterfeited worldwide, and the SkinVive/Volite dual naming creates an additional opening for confusion. Ask to see the sealed syringe, the batch number, the outer packaging and, if relevant, the import documentation — whichever name is on the box. A price substantially below the ranges above is a warning rather than a saving. Any clinic that becomes uncomfortable when asked these questions has already answered them.
Results Timeline
Timeframe | What usually happens |
Day 0 | Small bumps and mild redness at injection points. Settle within hours. Not a result — just the product. |
Day 1–3 | Skin feels softer and better hydrated. This is genuine, and it is the hydration rather than the remodelling. |
Week 2–4 | Visible improvement in smoothness and texture begins. The trial’s primary endpoint was measured at one month. |
Month 1 | Review appointment. Assess whether an optional touch-up syringe would add anything. Often it does not. |
Month 1–6 | Peak and sustained result. Smoothness improvement holds for up to six months with optimal treatment. |
Month 6–9 | Hydration benefits persist longer than smoothness. Gradual, even decline. |
Month 6–9 onward | Time for a maintenance session. |
Faster than Profhilo, which peaks at eight to twelve weeks, and considerably faster than Rejuran. If you have an event, SkinVive needs roughly four to six weeks of lead time rather than three months. That is a genuine practical advantage.
SkinVive vs Profhilo vs Rejuran
The three leading skin-quality injectables, compared honestly. They are not interchangeable, and none is best at everything.
| SkinVive (Volite) | Profhilo | Rejuran |
Active ingredient | Cross-linked HA (VYCROSS, BDDE) | 64mg HA, no cross-linker (NAHYCO) | c-PDRN from salmon DNA |
Category | Gel implant / filler class | Bio-remodeller | Regenerator |
Primary action | Deep hydration, cheek smoothness | Hydration + collagen bio-remodelling | Cellular repair and regeneration |
Best for | Dull, dehydrated, rough cheek skin | Dullness with mild laxity | Texture, fine lines, acne scars, damaged skin |
Contains lidocaine? | Yes — 0.3% | No | No |
Comfort | Most comfortable | Moderate | Least comfortable |
Sessions needed | 1 (+ optional touch-up) | 2 | 3–4 |
Bumps settle in | Hours | 4–6 hours | 24–48 hours |
Result appears | 2–4 weeks | 8–12 weeks | 6–8 weeks |
Lasts | 6 months (smoothness), 9 (hydration) | 6–9 months | 9–12 months |
FDA-approved for skin quality? | Yes — cheeks only | No | No |
Suitable if vegetarian? | Yes | Yes | No — salmon-derived |
Suitable with fish allergy? | Yes | Yes | No — contraindicated |
In short: SkinVive is the fastest, most comfortable and most convenient of the three, with the narrowest but best-evidenced indication. Profhilo gives a little more firming through genuine collagen stimulation. Rejuran is much the strongest for texture and scarring, and asks the most of you in return. The full framework for choosing between the three families sits on our skin booster page.
What SkinVive Will Not Do ?
- It will not add volume or change your face. For flatter cheeks or a weaker jawline you need dermal fillers. SkinVive shares their chemistry but not their purpose.
- It will not lift sagging skin. For true tissue descent, the honest answers are HIFU, Morpheus8, a thread lift or a facelift.
- It will not treat pigmentation. Melasma, dark patches and post-inflammatory hyperpigmentation need a pigmentation treatment.
- It will not correct acne scarring. That needs collagen remodelling — Rejuran, subcision, TCA CROSS, RF microneedling. See acne scar treatment.
- It will not relax expression lines. Frown lines and crow’s feet are muscle-driven. That is Botox.
- It will not work overnight. Four to six weeks of lead time before an event, minimum.
Are You a Good Candidate for SkinVive?
You are likely well-suited if you:
- Are 21 or older with dull, dehydrated or rough-textured cheek skin
- Want improved skin quality with no change whatsoever to your facial shape
- Prefer a single session over a multi-session course
- Want the most comfortable of the skin-quality injectables
- Are vegetarian, Jain, or will not accept animal-derived products
- Have any Fitzpatrick skin type, I through VI
- Have reasonable expectations — improvement in good skin, not transformation of damaged skin
SkinVive is not for you, or needs careful discussion, if you:
- Have a history of anaphylaxis, or of multiple severe allergies
- Are allergic to lidocaine
- Are allergic to Gram-positive bacterial proteins
- Have had a previous allergic reaction to any hyaluronic acid filler
- Have a history of excessive or thick scarring — safety has not been studied and additional scarring may result
- Are taking therapy that suppresses the immune response — increased infection risk
- Are pregnant or breastfeeding — safety has not been studied
- Have skin sores, pimples, rashes, hives, cysts or infection in the treatment area — treatment should be delayed
- Are planning laser treatment or a chemical peel soon afterwards — tell your doctor; there is a risk of inflammatory reaction
- Want volume, lift, pigment correction or scar treatment — this is the wrong category entirely
Why Choose Sarayu Clinics for SkinVive in Delhi ?
SkinVive is the easiest of the skin-quality injectables to administer and the easiest to describe carelessly. At Sarayu Clinics it is planned and administered by facial plastic and maxillofacial surgeon Dr. Adarsh Tripathi, alongside co-founder and celebrity aesthetician Dr. Nidhi Bhatia.
- We tell you it is Volite. Same product, different name. You will know exactly what is in the syringe and what it is called in every market.
- On-label and off-label, distinguished out loud. SkinVive is approved for cheeks. If we suggest it elsewhere, we will tell you it is off-label, explain why, and offer you a product that has been studied for that area.
- It is a cross-linked gel implant, and we treat it as one. Superficial microdroplet placement, full understanding of the facial vasculature beneath, and hyaluronidase kept on hand at every session. The risk is small. Preparedness is not optional.
- Full allergy screening. Lidocaine, previous HA reactions, anaphylaxis history, Gram-positive bacterial proteins. Four specific questions, asked every time.
- Verified Allergan product. Sealed syringe, batch number, packaging and import documentation shown on request, before it is opened.
- Honest efficacy. Fifty-eight per cent of trial participants saw measurable improvement at one month. That is a good number and it is not a hundred. We would rather quote it than promise a glow.
- An honest ‘no’. If your concern is volume, sagging, pigment or scarring, you will be told so at the consultation rather than after the syringe.
Medical Review & Sources
This page is for general information and is medically reviewed by the team at Sarayu Clinics under Dr. Adarsh Tripathi. It is not a substitute for an in-person consultation. SkinVive by Juvéderm is approved by the US FDA for intradermal injection to improve facial skin smoothness of the cheeks in adults aged 21 and over; safety and effectiveness in other areas have not been established. Product names, formulation and regulatory approval status vary by country and change over time; confirm current details at consultation. Sources:
How to Reach Us:
Phone: +91 9289111081 , +91 9289111082
Email: sarayuinquiries@gmail.com
Sarayu Clinics website: www.sarayuclinics.com
Facebook: https://www.facebook.com/sarayuclinic
Instagram: https://www.instagram.com/sarayuclinics/
Dr. Adarsh Tripathi’s profile: https://dradarshtripathi.com/
Online Booking: Visit our website https://sarayuclinics.com/contact-us/ to schedule appointments conveniently.
Is SkinVive the same as Juvéderm Volite?
Yes. They are the identical product from the same manufacturer, Allergan Aesthetics, sold under different brand names in different markets. SkinVive is the United States name, adopted after its FDA approval in May 2023. Juvéderm Volite is the name used across Europe, the UK, Asia and India. The internal product code is VYC-12L. If you are offered Volite when you asked for SkinVive, you are being offered the same thing — though you should have been told.
How much does SkinVive cost in Delhi?
Roughly Rs 25,000–45,000 per syringe, with two syringes for fuller coverage running Rs 45,000–80,000. Because SkinVive needs only one session — against two for Profhilo and three to four for Rejuran — it is often the least expensive of the three on a full-course basis. Ask which product SKU the clinic holds, and ask to see the sealed syringe and batch number.
Is SkinVive a filler?
Technically yes, and functionally no. It is cross-linked with BDDE and the FDA classifies it as a gel implant — the same device category as a dermal filler. But it is injected as microdroplets into the dermis rather than deeply for volume, and it adds no volume and does not change facial shape. The reason the distinction matters is that any hyaluronic acid injectable carries a small risk of unintentional injection into a blood vessel. Profhilo, by contrast, contains no cross-linker at all.
What is SkinVive approved for?
Intradermal injection to improve the smoothness of the cheeks, in adults aged 21 and over. That is the complete on-label indication. The manufacturer states that safety and effectiveness for treatment in other areas of the body have not been established. Use on the neck, under-eyes, hands or around the mouth is off-label — common, often reasonable, but you should be told when it is happening and offered alternatives that have been studied for those areas.
Does SkinVive hurt?
Less than the alternatives. SkinVive contains 0.3% lidocaine, a local anaesthetic built into the product itself, and is delivered through an ultrafine 32-gauge needle. Neither Profhilo nor Rejuran contains lidocaine. Combined with topical numbing cream, most patients find SkinVive the most comfortable of the skin-quality injectables.
How long does SkinVive last?
Improvement in cheek smoothness lasts up to six months with optimal treatment. Hydration benefits are reported for up to nine months. Maintenance every six to nine months sustains the result. Results typically become visible from around two to four weeks, with the trial’s primary endpoint measured at one month.
How effective is SkinVive really?
In the pivotal randomised, evaluator-blinded trial of 209 participants, 57.9% of those treated achieved at least a one-point improvement in cheek smoothness at one month. Patients also reported high satisfaction with how glowing, hydrated and refreshed their skin looked, sustained through six months. That is a genuine, respectable result for a single session with essentially no downtime — and it is not everyone. SkinVive improves skin that is already reasonably good.
SkinVive vs Profhilo — which should I choose?
They differ. SkinVive is faster (results at two to four weeks versus eight to twelve), needs one session rather than two, is more comfortable because it contains lidocaine, and has FDA approval for cheek smoothness. Profhilo contains no cross-linker, spreads from just five injection points per side, and produces slightly better firming because it stimulates collagen and elastin more actively. If you want convenience and hydration, SkinVive. If you want a little genuine firming alongside the glow, Profhilo.
Is SkinVive safe for Indian skin?
Yes. It is approved for all Fitzpatrick skin types, I through VI, and the clinical trials included diverse populations. Nothing in the treatment targets melanin or generates heat, so there is no meaningful risk of post-inflammatory hyperpigmentation in Fitzpatrick IV–V skin. The relevant safety considerations are allergy screening, product authenticity and injector skill — not skin tone.
Is SkinVive suitable for vegetarians?
Yes. The hyaluronic acid is produced by bacterial fermentation and the product contains no animal-derived material, making it suitable for vegetarian and Jain patients. Note that trace Gram-positive bacterial proteins remain from the manufacturing process, and allergy to these is a contraindication. This is a point of difference from the polynucleotide boosters such as Rejuran, which are derived from salmon DNA.
